Zoetis | ZTS - Sales Revenues

Stock Price
74.25
Daily Change
0.03 0.04%
Monthly
-39.50%
Yearly
-54.71%
Q2 Forecast
72.73

Zoetis reported $2.3B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AbbVie USD 15B 1.62B Mar/2026
Align Technology USD 1.04B 10M Mar/2026
Bayer EUR 13.41B 1.97B Mar/2026
Bristol-Myers Squibb USD 11.49B 1.01B Mar/2026
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Dentsply International USD 880M 81M Mar/2026
Eli Lilly USD 19.8B 500M Mar/2026
Henry Schein USD 3.37B 30M Mar/2026
Idexx Laboratories USD 1.14B 50M Mar/2026
Illumina USD 1.09B 70M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
J&J USD 24.1B 500M Mar/2026
Laboratory Of America USD 3.54B 20M Mar/2026
Merck USD 16.29B 110M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
Pacira USD 177M 19.87M Mar/2026
Perrigo USD 969M 141M Mar/2026
Pfizer USD 14.5B 3.08B Mar/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Quest Diagnostics USD 2.9B 90M Mar/2026
Sanofi EUR 11.24B 60M Mar/2026
Sanofi EUR 12.14B 65M Mar/2026
Zoetis USD 2.3B 100M Mar/2026